Precision medicine is a medical approach that considers a patient’s genes, environment, and lifestyle. In the realm of Alzheimer’s disease, experts are pushing for…
There are plenty of gifts designed specifically for people living with dementia that can be helpful, calming or stress-relieving, whether they’re intended to spur…
For decades, scientists blamed Alzheimer’s disease on the buildup of beta-amyloid protein plaques in the brain. But most clinical trials for drugs intended to…
On July 25th, European regulators said no to Eisai and Biogen’s anti-amyloid drug Leqembi for early stage Alzheimer’s. The European Medicines Agency (Europe’s version…
When entrepreneur Eben Pingree’s mother, 78, and father-in-law, 80, were both diagnosed with Alzheimer’s in the same week about two years ago, it shook…
November 6, 2024 Anica Leon-Weil is a licensed therapist and caregiver to her mother who lives with Alzheimer’s. “I want to stay in my…
At the 2024 Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid, Spain, scientists and drug development companies gathered to report on recent successes…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. When you’re concerned about…
Did you know 1/5 people who see a doctor with cognitive concerns are misdiagnosed? Dementia, in all its many forms — including Alzheimer’s, Parkinson’s,…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. What would you do…
October 16, 2024 Tim Mehrtens lives in New Zealand and was a caregiver to his mother with Alzheimer’s. Alzheimer’s is often described as a…
This article is part of the Diversity & Dementia series, produced by Being Patient with support provided by Eisai. Latino and Hispanic populations have…
Receiving an Alzheimer’s diagnosis is often a long, complex process, with many individuals facing delayed diagnosis or even misdiagnosis for years. A key reason…
“No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden,” Maria Shriver and George Vradenburg wrote…
While the world tracks the progress of disease-modifying Alzheimer’s anti-amyloids through the drug development and FDA approval pipeline, there are symptomatic treatments making their…